Fair Value Measurements of Financial Instruments (Tables)

12 Months Ended

Dec. 28, 2024

Financial instruments measured at fair value were as follows:


	Fair value as of measurement date		Quoted prices in active markets for identical assets (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Balance as of December 28, 2024
Cash and cash equivalents (including money market funds) (1)	$	22.5	$	22.5	$	—	$	—
Mutual funds (2)	$	11.6	$	11.6	$	—	$	—
Government securities (2)	$	6.1	$	—	$	6.1	$	—
Corporate bonds (2)	$	7.8	$	—	$	7.8	$	—

Interest rate swap derivative - liability (3)	$	(1.5)	$	—	$	(1.5)	$	—


Put option liability (4)	$	(5.9)	$	—	$	—	$	(5.9)


Balance as of December 30, 2023
Cash and cash equivalents (including money market funds) (1)	$	28.9	$	28.9	$	—	$	—
Mutual funds (2)	$	11.3	$	11.3	$	—	$	—
Government securities (2)	$	5.7	$	—	$	5.7	$	—
Corporate bonds (2)	$	7.8	$	—	$	7.8	$	—
Interest rate swap derivative - liability (3)	$	(3.5)	$	—	$	(3.5)	$	—

Put option liability (4)	$	(5.7)	$	—	$	—	$	(5.7)

Amounts in parentheses indicate liabilities.

The index below indicates the line item in the Consolidated Balance Sheets where the financial instruments are reported:

(1) "Cash and cash equivalents"

(2) Current portion - "Short-term investments"; Long-term portion - "Other Assets"

(3) Current portion - "Accounts payable and accrued expenses"; Long-term portion - "Other Long-Term Liabilities"

(4) "Other Long-Term Liabilities"